GO:0002366 leukocyte activation involved in immune response: Immune Cell Activation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002366 (leukocyte activation involved in immune response) describes the morphological and behavioral changes of leukocytes after exposure to antigens, mitogens, cytokines, cellular ligands, or soluble factors that initiate or perpetuate immunity.
• The term covers activation of neutrophils, mast cells, T cells, and other leukocytes, integrating innate and adaptive immune responses.
• Key signaling nodes include STAT4/STAT6, cGAS/STING, TLR8, and myeloperoxidase-dependent pathways.
• Neutrophil activation can proceed through NET formation, proinflammatory cytokine release, and multiple cell death modalities.
• Dysregulated leukocyte activation contributes to autoimmunity, chronic inflammation, and cancer immunopathology.
• CRISPR knockout, knock-in, and overexpression models enable causal dissection of genes controlling leukocyte activation.
Description
GO:0002366, leukocyte activation involved in immune response, is a biological process term that captures the coordinated morphological and behavioral changes leukocytes undergo when exposed to specific antigens, mitogens, cytokines, cellular ligands, or soluble factors, leading to the initiation or perpetuation of an immune response. This term is central to immunology because it unifies the early sensing events, intracellular signaling cascades, and effector functions that convert a resting leukocyte into an active participant in host defense. Leukocyte activation is not a single event but a continuum that includes receptor engagement, transcriptional reprogramming, metabolic shifts, and deployment of effector molecules such as cytokines, granule proteins, and neutrophil extracellular traps. Understanding GO:0002366 is therefore essential for researchers studying infection, autoimmunity, cancer immunosurveillance, and immunotherapy. The term is also a practical annotation target: genes involved in leukocyte activation are frequently enriched in transcriptomic and proteomic datasets from inflamed tissues, making GO:0002366 a useful lens for interpreting immune cell states. Because activation outcomes differ by leukocyte subtype and context, precise experimental models, including CRISPR-engineered cell lines and primary immune cells, are required to assign causal roles to individual genes.
leukocyte activation involved in immune response At A Glance
| GO ID | GO:0002366 |
|---|---|
| GO term | leukocyte activation involved in immune response |
| Ontology | biological_process |
| Synonym | immune cell activation during immune response; leucocyte activation during immune response; leukocyte activation during immune response |
| Definition | A change in morphology and behavior of a leukocyte resulting from exposure to a specific antigen, mitogen, cytokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response. |
| Major function | Initiation and perpetuation of immune responses through leukocyte activation |
| Related cell types | Neutrophils, mast cells, T cells, and other leukocytes |
| Key signaling pathways | STAT4/STAT6, cGAS/STING, TLR8, myeloperoxidase-dependent pathways |
| Disease relevance | Autoimmunity, chronic inflammation, cancer, and immune-mediated tissue damage |
What Is GO:0002366?
In our own words, GO:0002366 describes the process by which a leukocyte changes its shape and behavior after encountering a specific antigen, mitogen, cytokine, cellular ligand, or soluble factor, and as a result begins or sustains an immune response. It is a biological process term that encompasses the activation of immune cells during immune responses, including the signaling and effector changes that convert resting leukocytes into functional effectors.
Why Is leukocyte activation involved in immune response Important in Cell Biology?
GO:0002366 is important because leukocyte activation is the decisive step that converts immune surveillance into immune execution, and its dysregulation underlies a broad spectrum of human diseases, including autoimmunity, chronic inflammatory disorders, and cancer. Researchers use this term to annotate and interpret gene expression programs in activated neutrophils, mast cells, and T cells, and to connect signaling pathways such as STAT4/STAT6, cGAS/STING, and TLR8 to functional immune outcomes. Because activation states are dynamic and cell-type specific, precise experimental models are needed to determine which genes causally drive activation versus merely correlate with it.
• Defines the transition from resting to effector leukocyte states in innate and adaptive immunity.
• Provides a framework for interpreting transcriptomic and proteomic signatures of inflamed tissues.
• Links cytokine signaling, pattern recognition, and metabolic reprogramming to immune outcomes.
• Explains how neutrophils generate extracellular traps and proinflammatory mediators.
• Highlights mast cell contributions to both activation and inhibition of adaptive immunity.
• Connects myeloperoxidase activity to oxidative host defense and immunomodulation.
• Supports discovery of therapeutic targets in autoimmunity and chronic inflammation.
• Enables CRISPR-based causal testing of candidate genes in leukocyte activation.
• Guides vaccine and immunotherapy research by defining activation correlates.
• Provides a shared vocabulary for cross-study comparison of immune cell states.
What Happens During leukocyte activation involved in immune response?
Recognition and receptor engagement
In simple terms: The leukocyte first senses a danger signal or immune cue through its surface and intracellular receptors.
Activation begins when leukocytes encounter specific antigens, mitogens, cytokines, cellular ligands, or soluble factors that engage receptors and initiate intracellular signaling. In neutrophils, exposure to neutrophil extracellular traps can itself activate proinflammatory functions, illustrating that activation cues can be endogenous as well as microbial. DNA sensing through the cGAS/STING pathway provides another recognition route that couples cytosolic nucleic acid detection to immunoproteasome activation and adaptive T-cell immunity. In the liver, bepirovirsen can induce innate immune activation potentially through TLR8 signaling, showing that pharmacological agents can trigger leukocyte activation programs.
Intracellular signaling and transcriptional reprogramming
In simple terms: Signals from receptors are relayed inside the cell and switch on gene expression programs.
Engagement of cytokine and pattern recognition receptors activates transcription factors such as STAT4 and STAT6, which shape cellular and humoral immunity and are implicated in diverse human diseases. The cGAS/STING axis induces the immunoproteasome and supports adaptive T-cell immunity, linking innate sensing to transcriptional and proteolytic reprogramming. These signaling events change the morphology and behavior of leukocytes, consistent with the GO:0002366 definition.
Effector functions: cytokines, granules, and extracellular traps
In simple terms: Activated leukocytes release molecules and structures that fight pathogens and amplify inflammation.
Activated neutrophils can release proinflammatory mediators and form neutrophil extracellular traps, which in turn activate further proinflammatory functions of human neutrophils. Myeloperoxidase plays a dual role in immune response, contributing to oxidative host defense while also modulating inflammatory signaling. Mast cells can both activate and inhibit adaptive immune responses, indicating that effector outputs of leukocyte activation are context dependent. These effector mechanisms are central to the initiation or perpetuation of immune responses described by GO:0002366.
Cell fate decisions and resolution
In simple terms: After activation, leukocytes either resolve inflammation or undergo programmed cell death.
Neutrophils exhibit many ways to die, and the balance between survival, apoptosis, and other death modalities influences the duration and intensity of immune responses. Activation-induced cell fate decisions are therefore integral to GO:0002366, because they determine whether an immune response is sustained or resolved. Immune response profiles in human skin illustrate how activation states vary across tissue contexts and can be profiled experimentally.
Key Genes Involved in GO:0002366 leukocyte activation involved in immune response
The following genes and proteins are experimentally implicated in leukocyte activation involved in immune response, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| STAT4 | Transcription factor shaping cellular immunity | Links cytokine signaling to T-cell and NK-cell activation |
| STAT6 | Transcription factor shaping humoral immunity | Controls Th2-associated activation programs |
| STING1 | Cytosolic DNA sensor adaptor | Activates immunoproteasome and T-cell immunity |
| CGAS | Cytosolic DNA sensor | Initiates STING-dependent leukocyte activation |
| TLR8 | Endosomal nucleic acid sensor | Mediates innate immune activation by bepirovirsen |
| MPO | Myeloperoxidase enzyme | Dual role in oxidative defense and immune modulation |
| ELANE | Neutrophil serine protease | Contributes to neutrophil effector functions |
| PADI4 | Peptidylarginine deiminase | Supports NET formation and neutrophil activation |
| CXCL8 | Neutrophil chemoattractant cytokine | Amplifies neutrophil recruitment and activation |
| IL6 | Proinflammatory cytokine | Marker and mediator of leukocyte activation |
| TNF | Proinflammatory cytokine | Effector output of activated leukocytes |
| FCER1A | High-affinity IgE receptor subunit | Mast cell activation and adaptive immune modulation |
| KIT | Mast cell growth factor receptor | Mast cell survival and activation |
| IFNG | Type II interferon | Promotes leukocyte activation and immunoproteasome expression |
| PSMB8 | Immunoproteasome subunit | Induced by cGAS/STING activation |
| PSMB9 | Immunoproteasome subunit | Supports antigen processing in activated leukocytes |
| B2M | MHC class I light chain | Required for antigen presentation after activation |
How Is leukocyte activation involved in immune response Regulated?
Leukocyte activation involved in immune response is regulated at multiple levels. Cytokine signaling through STAT4 and STAT6 provides transcriptional control of cellular and humoral immunity, and dysregulation of these factors is linked to diverse human diseases. Innate sensing pathways, including cGAS/STING and TLR8, regulate the onset of activation and the downstream immunoproteasome program. Myeloperoxidase activity modulates the oxidative and inflammatory balance during immune responses. Mast cells can both activate and inhibit adaptive immune responses, indicating active regulatory checkpoints. Finally, cell death pathways in neutrophils determine the resolution phase of activation.
leukocyte activation involved in immune response and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| STAT4 | Autoimmunity and inflammatory disease | STAT4 knockout T-cell lines and primary T cells |
| STAT6 | Allergic and humoral immune disorders | STAT6 knockout Th2-polarized cultures |
| STING1 | Cancer immunosurveillance | STING1 knockout tumor and immune cell lines |
| MPO | Chronic inflammation and oxidative tissue damage | MPO knockout neutrophil models |
| PADI4 | NET-associated inflammatory pathology | PADI4 knockout neutrophil-like cells |
Autoimmunity and chronic inflammation
Dysregulated STAT4 and STAT6 signaling is implicated in diverse human diseases, including autoimmune and inflammatory conditions, because these transcription factors shape cellular and humoral immunity. Mast cell-mediated activation and inhibition of adaptive immune responses can also contribute to inflammatory pathology. Myeloperoxidase has a dual role in immune response, and its dysregulation can amplify tissue damage during chronic inflammation.
Cancer immunosurveillance and immunotherapy
DNA sensing via the cGAS/STING pathway activates the immunoproteasome and adaptive T-cell immunity, a process that is critical for anti-tumor immune responses and is being exploited in immunotherapy. Leukocyte activation states in the tumor microenvironment influence whether immune responses control or promote tumor growth.
Infection and innate immune pharmacology
Bepirovirsen induces innate immune activation in the liver potentially through TLR8 signaling, illustrating how pharmacological agents can engage leukocyte activation pathways for therapeutic benefit. Neutrophil extracellular traps activate proinflammatory functions of human neutrophils, linking activation to host defense and potential tissue injury. Neutrophil cell death modalities further influence infection outcomes.
From leukocyte activation involved in immune response-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for leukocyte activation? | CRISPR knockout in immune cell lines or primary leukocytes |
| Does a specific point mutation alter signaling? | CRISPR point-mutation knock-in |
| Does a disease-associated variant change activation? | Knock-in of the variant allele |
| Where and when is the protein expressed during activation? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression amplify activation? | CRISPR overexpression or cDNA overexpression |
| Which pathways are enriched in activated leukocytes? | CRISPR library screening with activation readouts |
How to Study the leukocyte activation involved in immune response Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptional changes during activation | Identifying activation gene signatures |
| Proteomics | Protein abundance and modifications | Immunoproteasome and effector protein analysis |
| Immunoblotting | Specific protein levels and phosphorylation | Validating STAT and STING pathway activation |
| ELISA | Cytokine secretion | Quantifying IL6, TNF, CXCL8 release |
| Live-cell imaging | Morphology and NET formation | Visualizing leukocyte activation dynamics |
| Flow cytometry | Surface markers and viability | Characterizing activated leukocyte subsets |
| CRISPR library screening | Gene requirement for activation | Discovering regulators of GO:0002366 |
Transcriptomic profiling of activation states
RNA sequencing of leukocytes before and after activation reveals transcriptional programs controlled by STAT4, STAT6, and innate sensing pathways. Immune response profiles in human skin demonstrate how tissue context shapes these programs.
Proteomic and immunoproteasome analysis
Mass spectrometry and immunoblotting can quantify immunoproteasome subunits such as PSMB8 and PSMB9 after cGAS/STING activation. Myeloperoxidase protein levels and activity can be measured to assess oxidative effector functions.
Imaging of neutrophil extracellular traps and morphology
Microscopy can visualize NET formation and morphological changes that define leukocyte activation. Live-cell imaging of neutrophil death modalities provides insight into resolution phases.
Functional assays for cytokine release and killing
ELISA and cytokine bead arrays quantify IL6, TNF, and CXCL8 release from activated leukocytes. Killing assays and oxidative burst measurements assess effector function.
How CRISPR Can Be Used to Study GO:0002366 leukocyte activation involved in immune response
Knockout
CRISPR knockout of candidate genes such as STING1, STAT4, or MPO in immune cell lines or primary leukocytes can test whether they are required for activation phenotypes, including cytokine release and immunoproteasome induction.
Point Mutation
Point-mutation knock-in can model disease-associated variants in genes like STAT4 or STAT6 to determine how specific amino acid changes alter leukocyte activation.
Knock-in
Tagged knock-in of endogenous loci enables tracking of protein localization and expression during leukocyte activation without overexpression artifacts.
Overexpression
Overexpression of activating factors such as STING1 or TLR8 pathway components can amplify activation signals and reveal sufficiency in leukocyte activation models.
How EDITGENE Supports leukocyte activation involved in immune response Research
Researchers studying leukocyte activation involved in immune response-related genes often need to determine whether a candidate gene is causally involved in activation or merely correlated with it. EDITGENE provides CRISPR-based cell model services that enable precise, reproducible experiments to answer these questions.
Contact EDITGENE today to design your custom CRISPR model for leukocyte activation involved in immune response research.
Frequently Asked Questions About leukocyte activation involved in immune response
What is GO:0002366?
GO:0002366 is the Gene Ontology term for leukocyte activation involved in immune response, defined as a change in morphology and behavior of a leukocyte resulting from exposure to a specific antigen, mitogen, cytokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response.
What genes are involved in leukocyte activation involved in immune response?
Genes experimentally implicated include STAT4, STAT6, STING1, CGAS, TLR8, MPO, PADI4, and immunoproteasome subunits such as PSMB8 and PSMB9.
How is leukocyte activation involved in immune response regulated?
It is regulated by cytokine signaling through STAT4 and STAT6, innate sensing via cGAS/STING and TLR8, myeloperoxidase activity, and cell death pathways in neutrophils.
What cell types undergo leukocyte activation involved in immune response?
Neutrophils, mast cells, T cells, and other leukocytes undergo activation during immune responses.
Why is GO:0002366 important in disease?
Dysregulated leukocyte activation contributes to autoimmunity, chronic inflammation, and cancer, making it a key area for therapeutic research.
What methods are used to study leukocyte activation involved in immune response?
Common methods include RNA-seq, proteomics, immunoblotting, ELISA, live-cell imaging, flow cytometry, and CRISPR library screening.
How can CRISPR help study GO:0002366?
CRISPR knockout, knock-in, point mutation, and overexpression models allow causal testing of genes in leukocyte activation pathways.
What is the role of neutrophil extracellular traps in leukocyte activation?
Neutrophil extracellular traps can activate proinflammatory functions of human neutrophils, linking NET formation to further leukocyte activation.
Does the cGAS/STING pathway activate leukocytes?
Yes, DNA sensing via cGAS/STING activates the immunoproteasome and adaptive T-cell immunity, a key component of leukocyte activation.
What is the role of myeloperoxidase in immune response?
Myeloperoxidase has a dual role in immune response, contributing to oxidative defense and modulating inflammatory signaling.
Conclusion
GO:0002366, leukocyte activation involved in immune response, is a foundational biological process term that captures how leukocytes sense and respond to immune cues. Its mechanisms span receptor recognition, STAT and STING signaling, effector molecule release, and cell fate decisions, with direct relevance to autoimmunity, inflammation, and cancer. CRISPR-based models from EDITGENE provide a rigorous path to dissect the causal roles of individual genes in this process.
References
- 1. Ermler ME et al.. 2026. Bepirovirsen induces innate immune activation in the liver potentially through TLR8 signaling.. JHEP Rep 8(9):101923 PMID: 42264034
- 2. Dömer D et al.. 2021. Neutrophil Extracellular Traps Activate Proinflammatory Functions of Human Neutrophils.. Front Immunol 12:636954 PMID: 34168641
- 3. Tolomeo M et al.. 2024. STAT4 and STAT6, their role in cellular and humoral immunity and in diverse human diseases.. Int Rev Immunol 43(6):394-418 PMID: 39188021
- 4. Toniato E et al.. 2017. Activation and inhibition of adaptive immune response mediated by mast cells.. J Biol Regul Homeost Agents 31(3):543-548 PMID: 28952282
- 5. Arnhold J. 2020. The Dual Role of Myeloperoxidase in Immune Response.. Int J Mol Sci 21(21) PMID: 33137905
- 6. Meyer T et al.. 2007. Immune response profiles in human skin.. Br J Dermatol 157 Suppl 2:1-7 PMID: 18067623
- 7. Pérez-Figueroa E et al.. 2021. Neutrophils: Many Ways to Die.. Front Immunol 12:631821 PMID: 33746968
- 8. Wang X et al.. 2023. DNA sensing via the cGAS/STING pathway activates the immunoproteasome and adaptive T-cell immunity.. EMBO J 42(8):e110597 PMID: 36912165
